PRECISION BIOSCIENCES INC (DTIL) [Rocket]

Overview

PRECISION BIOSCIENCES INC (DTIL)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/22/2023	4	Kelly John Alexander (CFO) has filed a Form 4 on PRECISION BIOSCIENCES INC
08/21/2023	8-K/A	Financial Statements and Exhibits  Interactive Data
08/04/2023	8-K	Quarterly results
08/04/2023	10-Q	Quarterly Report for the period ended June 30, 2023
07/06/2023	8-K	Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
06/16/2023	EFFECT	Form EFFECT - Notice of Effectiveness:
06/09/2023	4	Barton Shane (VP & Corporate Controller) has filed a Form 4 on PRECISION BIOSCIENCES INC

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
Revenues	25.1	115.5	24.3	22.2	10.9	6.5
Revenue growth	-78.3%	375.7%	9.2%	104.3%	67.8%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	28.3
Gross profit	25.1	115.5	24.3	22.2	10.9	-21.9
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	-337.1%
Selling, general and administrative	125.5	154.9				0.1
Research and development			98.1	82.4	45.1
General and administrative			36.1	27.0	13.7
EBITA	-100.3	-33.4	-109.8	-87.2	-47.8	-21.9
EBITA margin	-399.5%	-28.9%	-452.2%	-392.1%	-439.3%	-337.1%
Amortization of intangibles	0.1				0.1
EBIT	-100.4	-33.4	-109.8	-87.2	-47.9	-21.9
EBIT margin	-399.9%	-28.9%	-452.2%	-392.1%	-440.2%	-337.1%
Pre-tax income	-111.6	-30.6	-109.0	-92.9	-46.0	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%		0.0%	0.0%
Net income	-111.6	-30.6	-109.0	-92.9	-46.0	0.0
Net margin	-444.8%	-26.5%	-448.9%	-417.6%	-423.0%	0.0%

Diluted EPS	($1.27)	($0.52)	($2.09)	($2.21)	($2.92)	$0.00
Shares outstanding (diluted)	87.9	58.7	52.0	42.0	15.8	15,906.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.